Home
Learning Center Contact Book a Consultation
← Medical Weight Loss
Weight Loss Medications

Tirzepatide in Utah: How It Works, and What to Expect

Tirzepatide — sold as Mounjaro and Zepbound — is a dual-action medication that's become one of the most requested weight loss treatments available. Here's how it actually works, how it compares to semaglutide, and what real medical oversight looks like at Abbott.

Reviewed by McKell Johnson, FNP-BC, Clinical Director · Originally developed by Dr. Justin Abbott, D.O., Founder
★★★★★5.0 from 55 Google reviews
✓ FNP-BC Board Certified ✓ Evidence-Based Care ✓ Personalized Treatment Plans
Understanding Tirzepatide

A Dual-Action Medication for Weight Loss

Tirzepatide was originally developed and FDA-approved in 2022 under the brand name Mounjaro, for type 2 diabetes. In late 2023, the same medication was FDA-approved specifically for chronic weight management under the brand name Zepbound. Both contain the exact same active ingredient — the brand you're prescribed depends on your diagnosis, and your provider will walk through which one fits your situation.

What makes tirzepatide different from single-action GLP-1 medications like semaglutide is its dual mechanism: it acts on both the GLP-1 receptor and a second receptor, GIP, which appears to have an additive effect on appetite regulation and blood sugar control. In practical terms, it's working two of the pathways involved in hunger and metabolism instead of one.

What Patients Notice

Reduced appetite and fewer food cravings
Feeling full sooner and staying full longer
Steadier blood sugar between meals
Mild nausea or digestive adjustment, especially early on
Gradual, consistent weight loss over weekly doses
Watch

What to Know Before You Start Tirzepatide

A short clip from our founder, Dr. Abbott, on how tirzepatide therapy works alongside supportive nutrients. Today, treatment is provided by McKell Johnson, FNP-BC.

Tirzepatide & Glycine: Boost Muscle & Collagen
Tirzepatide vs. Semaglutide

How the Two Compare

Both medications work, and both are backed by strong clinical trial data. Clinical trials comparing the two have generally shown tirzepatide producing somewhat greater average weight loss than semaglutide at maximum doses — but that's an average across large study populations, and individual response varies. We help you choose based on your labs and health history, not which name you've heard more often.

Dual GLP-1 / GIP

Tirzepatide

Brand names: Zepbound (weight loss), Mounjaro (diabetes). Targets two hormone receptors for enhanced results in many patients.

  • Once-weekly injection
  • Up to 22% average weight loss in trials
  • Strong results for insulin resistance
  • FDA-approved for obesity since 2023
GLP-1 Agonist

Semaglutide

Brand names: Wegovy (weight loss), Ozempic (diabetes). The most studied GLP-1 medication, FDA-approved for chronic weight management since 2021.

  • Once-weekly injection
  • 15–17% average weight loss in trials
  • Also improves cardiovascular markers
  • Available as oral pill (Wegovy) since 2025
From Our Care Team

Patients come in asking which medication is 'stronger,' as if that's the only variable that matters. The better question is which one your body will tolerate well enough that you actually stay on it long enough to get results. Tirzepatide's dual mechanism gives it an edge in average trial outcomes, but the right medication is the one that fits your labs, your history, and your life.

Reviewed for accuracy by McKell Johnson, FNP-BC, Clinical Director, and the Abbott Health & Wellness care team.

Related

Often discussed alongside tirzepatide: Semaglutide, Topamax, Phentermine, and what GLP-1 side effects actually feel like.

Considering Telehealth Instead?

Tirzepatide is one of the medications most heavily marketed by online compounding subscriptions right now. Before you compare prices, see what the FDA has actually said about compounded GLP-1 safety and how the real costs compare in our Telehealth vs. Local Clinic breakdown.

What Patients Say

Coming from Richfield? We're about 20 minutes north on US-89. See our Richfield patient guide for directions, hours and what to expect.

Tirzepatide Guides

Tirzepatide Questions, Answered

Plain-English answers for patients considering tirzepatide in Utah. We serve Salina, Richfield, Manti, Gunnison, Ephraim and Central Utah.

Common Questions

Tirzepatide FAQs

What patients ask most before their first appointment.

Tirzepatide is a dual agonist that acts on both the GLP-1 receptor and a second receptor, GIP, which appears to have an additive effect on appetite regulation and metabolic response. In practical terms, it slows digestion, reduces appetite, and helps your brain register fullness sooner — hitting two of the pathways involved in hunger and blood sugar regulation instead of one.
Yes. Both contain the same active ingredient, tirzepatide. Mounjaro was FDA-approved first, for type 2 diabetes. Zepbound is the same medication FDA-approved specifically for chronic weight management. Your provider will prescribe under whichever brand fits your diagnosis and insurance or pharmacy situation.
Clinical trials have generally shown tirzepatide producing somewhat greater average weight loss than semaglutide, but that's an average across large study populations — individual response varies. The right choice depends on your labs, metabolic history, and how your body responds, not a universal winner. We help you decide based on your specific situation, not which name you've heard more often. See our full semaglutide vs. tirzepatide breakdown.
The most common side effects are gastrointestinal — nausea, constipation, and digestive adjustment, particularly early in treatment and after dose increases. These typically improve as your body adjusts and are managed by starting at a low dose and titrating gradually. Your provider will discuss the full risk and benefit profile at your consultation. See our detailed guide on what GLP-1 side effects actually feel like.
Tirzepatide is generally more expensive than semaglutide, reflecting its dual-receptor mechanism and dosing. Medical weight loss at Abbott is self-pay — we accept HSA/FSA funds, CareCredit financing, and cash or card. We're transparent about current pricing before you commit to anything. See our full breakdown of what drives GLP-1 medication cost.
No. Abbott Health & Wellness in Salina, Utah offers provider-led tirzepatide weight loss programs for patients across Sevier County, including Richfield, Manti, Gunnison, Fillmore, and surrounding communities. We are the only provider-led functional medicine and med spa practice in Central Utah offering this level of care.
It depends on what you're actually being prescribed. Many low-cost telehealth subscriptions rely on compounded tirzepatide rather than FDA-approved Zepbound or Mounjaro. In September 2025 the FDA issued warning letters to more than 50 companies compounding or marketing GLP-1 medications, and has logged hundreds of adverse event reports tied to compounded semaglutide and tirzepatide — many involving dosing errors from self-administered multidose vials. See our full safety breakdown before choosing a provider.
Yes. Abbott Health & Wellness in Salina offers provider-led tirzepatide programs for patients in Sevier and Sanpete counties, including Richfield, Manti, Gunnison and Fillmore. See our full GLP-1 program or service areas.
Tirzepatide starts low and increases in steps. The labeled Zepbound schedule begins at 2.5 mg weekly for four weeks, then 5 mg, and can increase in 2.5 mg steps after at least four weeks at each dose, with maintenance doses of 5, 10 or 15 mg. Your provider sets the pace and the dose that fits your response.
Yes, and it's common when progress stalls or side effects limit your dose. It isn't a one-to-one dose swap, so your provider chooses the timing and starting dose of the new medication. See how switching works.
Prioritize protein, add resistance training, and track body composition instead of just the scale. Read how much protein you need on a GLP-1, or see our guide to a GLP-1 weight loss plateau.
Yes. Abbott Health & Wellness in Salina offers provider-led tirzepatide (Zepbound) programs for patients across Central Utah, including Richfield, Manti, Gunnison and Ephraim, with labs, in-person visits and body composition tracking. See our Richfield guide and service areas.
Yes. Tirzepatide is a prescription medication. At Abbott, McKell Johnson, FNP-BC reviews your health history and labs at a consultation to decide whether it is appropriate for you.
Get Started

Find Out If Tirzepatide Is Right For You.

Book a consultation and we'll review your labs and health history to see whether tirzepatide, semaglutide, or another approach makes the most sense for your goals.